UnitedHealth is experiencing a temporary margin reset due to pressure in Medicare Advantage and weaker execution, leading to withdrawn guidance and uncertainty reflected in its current valuation around 17 times next twelve months price-to-earnings. However, this is viewed as a temporary issue rather than a structural problem. The company is restoring insurance profitability through premium increases and membership adjustments, while its Optum Health segment is shifting focus from growth to execution. Upcoming earnings reports are crucial for management to regain investor trust and demonstrate stabilization of key business drivers, potentially leading to a re-rating if margins improve.
The SCHD ETF has returned just under 2% in the past month, outperforming the S&P 500 ETF (SPY) by nearly 1%. Year-to-date, about 30 SCHD holdings have more than doubled the returns of SPY, which has returned 9.8%. Additionally, 31 SCHD holdings are t...
Elevance Health and UnitedHealth Group, two of the largest U.S. health insurers, are set to report their second-quarter earnings this week. Investors and analysts are watching closely to see if these companies have maintained control over rising medi...
